|
Volumn 12, Issue 4, 2002, Pages 611-614
|
The discovery of acylated β-amino acids as potent and orally bioavailable VLA-4 antagonists
a a a a a a a a a a a a a a a a a a a a more.. |
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA AMINO ACID;
BETA1 INTEGRIN;
BLOCKING AGENT;
CD29 ANTIGEN ANTAGONIST;
UNCLASSIFIED DRUG;
AMINO ACID;
AUTACOID;
VERY LATE ACTIVATION ANTIGEN 4;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANTIGEN BINDING;
ARTICLE;
BIOAVAILABILITY;
COMBINATORIAL CHEMISTRY;
CONTROLLED STUDY;
DRUG POTENCY;
DRUG SPECIFICITY;
MICROSOME;
NONHUMAN;
PLASMA PROTEIN BINDING;
RAT;
ACYLATION;
ANIMAL;
DRUG ANTAGONISM;
DRUG SCREENING;
METABOLIC CLEARANCE RATE;
METABOLISM;
ORAL DRUG ADMINISTRATION;
PROTEIN BINDING;
SPRAGUE DAWLEY RAT;
STEREOISOMERISM;
STRUCTURE ACTIVITY RELATION;
SYNTHESIS;
ACYLATION;
ADMINISTRATION, ORAL;
AMINO ACIDS;
ANIMALS;
BIOLOGICAL AVAILABILITY;
COMBINATORIAL CHEMISTRY TECHNIQUES;
DRUG EVALUATION, PRECLINICAL;
INFLAMMATION MEDIATORS;
INTEGRIN ALPHA4BETA1;
METABOLIC CLEARANCE RATE;
PROTEIN BINDING;
RATS;
RATS, SPRAGUE-DAWLEY;
STEREOISOMERISM;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 18244374489
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0960-894X(01)00818-6 Document Type: Article |
Times cited : (13)
|
References (20)
|